One-third of hepatitis C prescriptions receive absolute denial from insurers
(HealthDay)—Insurers are increasingly denying prescriptions of direct-acting antiviral (DAA) drugs for hepatitis C virus treatment, according to a study published online June 7 in Open Forum Infectious Diseases.
Jul 26, 2018
1
1